TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 35 filers reported holding TRANSLATE BIO INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $19,093,000 | +78.2% | 693,266 | +6.7% | 0.38% | +61.1% |
Q1 2021 | $10,717,000 | -9.6% | 649,900 | +1.0% | 0.23% | -6.8% |
Q4 2020 | $11,860,000 | +35.6% | 643,500 | +0.1% | 0.25% | +13.1% |
Q3 2020 | $8,746,000 | -26.2% | 642,646 | -2.8% | 0.22% | -31.7% |
Q2 2020 | $11,850,000 | +44.1% | 661,268 | -19.8% | 0.32% | -4.4% |
Q1 2020 | $8,225,000 | +6.4% | 825,000 | -13.2% | 0.34% | +39.3% |
Q4 2019 | $7,733,000 | -23.9% | 950,000 | -7.3% | 0.24% | -39.8% |
Q3 2019 | $10,158,000 | -20.3% | 1,025,000 | +1.6% | 0.40% | -12.1% |
Q2 2019 | $12,746,000 | +23.9% | 1,009,179 | 0.0% | 0.46% | +16.4% |
Q1 2019 | $10,284,000 | +35.9% | 1,009,179 | 0.0% | 0.40% | +10.9% |
Q4 2018 | $7,569,000 | -25.0% | 1,009,179 | 0.0% | 0.36% | -2.2% |
Q3 2018 | $10,092,000 | -21.1% | 1,009,179 | -0.2% | 0.36% | -25.8% |
Q2 2018 | $12,790,000 | – | 1,011,079 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |